±±Ê¦´óϸ°ûÉúÎïѧ£º r5fz6"
Ò»¡¢ Ãû´Ê½âÊÍ£º d"e%tsj
1£® ͬԴºÐ£¨homeobox£©£¨96¡¢99¡¢91£© /^es0$Co.
2£® PCR£¨96£© WP#_qqO
3£® ·ºËØ£¨ubquitin£©£¨96£© Wvzzjcr(j
4£® °é·Ö×Ó£¨chapron£©£¨96£© `mHOgS>|
5£® ת¼Òò×Ó£¨trascription factor£©£¨96£© DRFuvU+e
6£® DG£IP3£¨96£© OKLggim{
7£® »ùÒòÇóý£*****ene knock out£©£¨96¡¢00£© wshp{ y
8£® ΢¹Ü×éÖ¯ÖÐÐÄ£¨MTOC£©£¨96¡¢01£© %N AFU/&
9£® ¶ËÁ£Ã¸£¨telomerase£©£¨96£© O+UV\
10£® µ°°×·ÖÑ¡£¨protein sorting£©£¨96¡¢99¡¢00£© BD-c 0-+m
11£® Transformation£¨92£© +8@`lDnr
12£® TransfectionתȾ£¨92£© o-e,
13£® TranscytosisתÒÆ×÷Óã¨92£© *~lg
U4
14£® Transductionתµ¼£¨92£© ? 3E_KGI
15£® Transdetermination£¨92£© h/+I-],RF
16£® Transdifferentiation£¨92£© l!2Z`D_MD
17£® Transgenic animalת»ùÒò¶¯Î92£© {-7yZ]OO$
18£® Rb£1£¨92£© >a`zkl
19£® P53£¨92¡¢91£© qer
'V
20£® C£jun£¨92£© :`"T Eif
21£® ΢¹Û½áºÏµ°°×MAPS£¨99¡¢91£© oJ;O>J@c
22£® °ûÄÚÌ壨99£© SAxa7B/U2
23£® Cyclin dependent kinase inhibitor(CDKI)(99) U"Ob@$ROFy
24£® G£protein£¨91£© LXfeXWw?,
25£® Restriction point£¨91£© <W[8k-yOV`
26£® Antipost£¨91£© cZX&itVc:
27£® Capping£¨91£©
AqKx3p6
28£® TATAbox£¨91£© V<7K!<g)b
29£® cDNA library£¨90£© @p` CAB
30£® Aritotic apparatus£¨90£© iYQy#kO
31£® ¿çĤÐźŠtransmembrane signal£¨90£© ![D,8]GD
32£® ´ÙÓÐË¿·ÖÁÑÔ mitogen£¨90£© P(i2bbU
33£® Nuclear lamina£¨90£© j[ZniD
34£® ϸ°ûµòÍö£¨apotosis£©£¨00£© GTIfrqT
35£® ϸ°ûÍâ»ùÖÊ£¨00¡¢01£© Fh4w0u*Q
36£® ϸ°û·Ö»¯£¨00£© JO6vzoS3
37£® ϸ°ûÐźÅתµ¼£¨signal transduction£©£¨00£© =28H^rK{
38£® ¿Ë¡£¨00£© D}/.;]w<[&
39£® »ùÒò×飨00£© B+[Q$Q"
40£® Caspase£¨00£© e4H0<h
}{
41£® ת¼Òò×Ó£¨00£© hA1hE?c`
42£® ÅßÌ¥¸Éϸ°û£¨01£© adr^6n6v
43£® ¼¤¹â¹²¾Û½¹ÏÔ΢¾µ£¨01£© F*( A; N_y
44£® DNAоƬ£¨01£© N4(VRA
¶þ¡¢ ÎÊ´ðÌ⣺ >s?;2T2"yx
1£® ÊÔÊöÀÒ°±Ëáµ°°×¼¤Ã¸ÊÜÌåµÄÐźÅͨ·£¨96£© @`*YZq>p
2£® ÊÔ¾ÙÀý˵Ã÷ÐÅʹϵͳÖÐÓëϸ°ûÔöÖ³Óйصļ¤Ã¸¼°Æ书ÄÜ£¨95£© tsC|R~wW
3£® ÊÔ·ÖÎöÐźÅתµ¼£¨transduction£©µÄ¼¸Ìõͨ·µÄ¹²ÐÔÓëÌØÐÔ£¨92£© Tq; "_s
4£® µ°°×ÖʵÄÁ×ËữÓëÈ¥Á×ËữÔÚϸ°ûÐźÅϵͳ´«µ¼ÖеÄ×÷Óã¨93¡¢99£© Ywk[VD+.
5£® ÊÔÊöÁ×õ¥Ë®½âøC£¨PLC£©µÄ·ÖÀ༰ÔÚϸ°ûÐźÅתµ¼ÖеÄ×÷Óᣣ¨01£© 9@*>$6
6£® ÊÔÊöϸ°û½ÓÊÜ»¯Ñ§Ðźźóµ÷½Ú»ùÒò±í´ïµÄ;¾¶£¨94£© iKH T
7£® ÊÔÊöϸ°ûÖÜÆÚ¸÷½×¶ÎÖÐCyclins£CdksµÄµ÷¿Ø×÷Óã¨96£© (s*Uz3sq
8£® ¾ÙÀý˵Ã÷CKIÔÚϸ°ûÔöÖ³µ÷¿ØÖеÄ×÷Óã¨96£© r9'H7J
9£® ÏêÊöcyclins£cdksϵͳÔÚϸ°ûÖÜÆÚG2/M¼°M/G1¹ý¶ÈÖÐÈçºÎÊܵ½µ÷¿ØµÄ£¿ÒÑÖªÄÇЩ·Ö×Ó¿ÉÄÜÊÇcdksµÄµ×Îï¼°ÆäÔÚÁ×ËữÓëÈ¥Á×Ëữ¹ý³ÌÖжÔϸ°û½á¹¹Ó빦Äܱ仯µÄÓ°Ï죨95£© e[&3K<
10£® Cdc2ºÍcyclin»ùÒò£¨cdc13£©ÈçºÎµ÷¿Øϸ°ûÖÜÆÚÔËתµÄÏÖ´ú¸ÅÄ92¡¢94£© x(N}^Hu
11£® Ϊʲô˵µ°°×ÖÊÁ×Ëữ£È¥Á×ËữºÍ·ºËؽ鵼µÄµ°°×ÖÊË®½â£¨UPP£©µÄ»¥Ïàе÷Íƶ¯Ï¸°ûÖÜÆÚµÄÔËת£¿£¨01£© 1L
qJ@v0
12£® ϸ°ûÔöÖ³µ÷¿ØµÄ·Ö×Ó»úÖÆ£¨00£© \~j(ui|
13£® ϸ°û¹Ç¼ÜÔÚϸ°ûÔöÖ³ÖÜÆÚÖеÄ×÷Óã¨00£© 7TY"{?~O5
14£® P34cdc2µÄÐÔÖʼ°Æä×÷Óõ×ÎïÊÇʲô£¿½«ÒýÆðºÎÖÖЧӦ£¿£¨91£© v")
W@haU
15£® ϸ°ûÓÐË¿·ÖÁÑÖзĴ¸Ìå΢¹ÜµÄ¶¯Á¦Ñ§±ä»¯»úÀí¼°ÆäÓëȾɫÌåÔ˶¯µÄ¹Øϵ£¨95£© yVv3S[J
16£® ΢¹ÜµÄ×é×°ÓëÈ¥×é×°ÔÚϸ°ûÓÐË¿·ÖÁѹý³ÌÖеĶ¯Ì¬±ä»¯¼°Æä×÷Óã¨92£© ?+tZP3'
17£® ϸ°ûÓÐË¿·ÖÁѹý³ÌÖзĴ¸ÌåµÄ×é×°ÓëÈ¥×é×°µÄ¶¯Ì¬±ä»¯¼°Æ书ÄÜ£¨93£© T
Bfl9Q
18£® ϸ°ûÓÐË¿·ÖÁѺóÆÚȾɫÌå·ÖÀëÇ÷ÏòÁ½¼«µÄ»úÀíÊÇÈçºÎÖ¤Ã÷µÄ£¿£¨90£© ' *C)S
19£® ÊÔÊöÖÐÐÄÁ£/¶¯Á£È¥ÔÚϸ°ûÓÐË¿·ÖÁÑÖеÄ×÷Óã¨99£© 5)i0g
20£® KinetochoreÊÇÓÉÄļ¸ÖÖÖ÷Òªµ°°××é³É£¬ÓÃʲô·½·¨Ñо¿Æ䶨λ¡¢·Ö×ÓÁ¿¼°»úÄÜ£¿£¨90£© Pg C]@Q%
21£® ÊÔ·Ö±ðÐðÊöÈËÀà×ÅË¿Á£ºÍ¶¯Á£µÄ»ù±¾×é³É¼«ÆäÄ¿Ç°ËùÖªµÄ¹¦ÄÜ£¨01£© ~
mo`
22£® ÊÔÊöϸ°û±à³ÌÐÔËÀÍö£¨programmed cell death£©ºÍϸ°ûµòÍö£¨apoptosis£©µÄÌØÕ÷ºÍÉúÀíѧÒâÒå¼°Æä¿ÉÄܵĻùÒòµ÷¿Ø£¬ÄãÈÏΪÑо¿µÄÖصãÓ¦·ÅÔں䦣¿ÎªÊ²Ã´£¿£¨95£© 'E8Qi'g
23£® ApoptosisÓëneerosisµÄ¼ì²âÓëÇø±ð£¨99£© TL:RB)- <
24£® ÈçºÎ¼ø±ðϸ°ûµòÍöÓ뻵ËÀ¡£Ï¸°ûµòÍöÑо¿µÄÖØÒªÒâÒåÊÇʲô£¿£¨01£© SntYi0,`
25£® ÊÔÊöunipintin£proteasen proteolytic system£¨99£© TBYL~QQD\C
26£® ÒÑÖªÓÐÄÇЩÖ÷ÒªµÄ°©»ùÒòÓëÒÖ°©»ùÒòÓëϸ°ûÖÜÆڵĵ÷¿ØÓйأ¿²¢¾ÙÀý˵Ã÷£¨93£© H hH'\-[t
27£® Oncogene¼°Æä²úÎïÓëϸ°ûÔöÖ³µÄ¹Øϵ£¨91£© DTVnQC
28£® ¾ÙÀý˵Ã÷oncogene¡¢growth factors¼°ÊÜÌåÖ®¼äµÄÁªÏµ£¨90£© V7i`vo3Cc
29£® ÊÔÊöºáÎƼ¡¡¢Ï¸°ûÄÚ´Öϸ˿Á½·Ö×ӵĽṹ¡¢¸÷ÖÖÖ÷Òªµ°°×³É·ÖÔÚ¼¡ÈâÊÕËõÖеÄ×÷Óᣣ¨90£© VO?NrKyeW
30£® ÊÔÊöϸ°ûÖÊÃþÉÏĤµ°°×µÄ¼¸ÖÖÀàÐͼ°Æ书ÄÜ£¨95£© x"De
9SB
31£® ÊÔÊöÃâÒßѧ¼¼ÊõÔÚϸ°ûÉúÎïѧÑо¿ÖеÄÓ¦Óã¨92£© eA^|B zU
32£® ͬԴºÐµÄ·¢ÏÖ¼°ÆäÔÚÉúÎïÖеÄÖØÒªÒâÒ壨92£© YHAg4eb8
33£® ÈçÒÑ֪ijһ»ùÒòƬ¶ÎÐòÁкÍÒÑ»ñµÃijһµ¥¿Ë¡¿¹ÌåÓ¦ÓúÎÖÖ¼¼Êõ·Ïߵõ½ËüµÄcDNA¿Ë¡£¨94£© 7^X_tQf
34£® ¾ÙÀý˵Ã÷ÃâÒßÓ«¹âFISH¡¢ÃâÒߵ羵ÖîÏî¼¼ÊõµÄ»ù±¾ÔÀí¼°ÆäÔÚϸ°ûÉúÎïѧÑо¿Öеĸ÷½â¾öʲôÎÊÌ⣨94£© Xq^{P2\w1
35£® ÄãµÄ˶ʿÂÛÎÄÌá³öÁËʲôÎÊÌ⣿ÈçºÎ½â¾öµÄ£¿½áÂÛÊÇʲô£¿£¨96¡¢94¡¢00£©